MX2023000580A - Derivados de 7-(piperidin-1-il)-4h-pirimido[1,2-b]piridazin-4-ona como moduladores alostericos positivos del receptor muscarinico m4 de la acetilcolina. - Google Patents

Derivados de 7-(piperidin-1-il)-4h-pirimido[1,2-b]piridazin-4-ona como moduladores alostericos positivos del receptor muscarinico m4 de la acetilcolina.

Info

Publication number
MX2023000580A
MX2023000580A MX2023000580A MX2023000580A MX2023000580A MX 2023000580 A MX2023000580 A MX 2023000580A MX 2023000580 A MX2023000580 A MX 2023000580A MX 2023000580 A MX2023000580 A MX 2023000580A MX 2023000580 A MX2023000580 A MX 2023000580A
Authority
MX
Mexico
Prior art keywords
piperidin
acetylcholine receptor
muscarinic acetylcholine
pyrimido
pyridazin
Prior art date
Application number
MX2023000580A
Other languages
English (en)
Spanish (es)
Inventor
P Jeffrey Conn
Thomas Jensen
Craig W Lindsley
Darren W Engers
Alison R Gregro
Kayla J Temple
Madeline F Long
Anna E Ringuette
Logan A Baker
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Publication of MX2023000580A publication Critical patent/MX2023000580A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
MX2023000580A 2020-07-15 2021-07-15 Derivados de 7-(piperidin-1-il)-4h-pirimido[1,2-b]piridazin-4-ona como moduladores alostericos positivos del receptor muscarinico m4 de la acetilcolina. MX2023000580A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063052085P 2020-07-15 2020-07-15
PCT/US2021/041836 WO2022015988A1 (en) 2020-07-15 2021-07-15 7-(piperidin-1-yl)-4h-pyrimido[1,2-b]pyridazin-4-one derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4

Publications (1)

Publication Number Publication Date
MX2023000580A true MX2023000580A (es) 2023-02-13

Family

ID=77051222

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023000580A MX2023000580A (es) 2020-07-15 2021-07-15 Derivados de 7-(piperidin-1-il)-4h-pirimido[1,2-b]piridazin-4-ona como moduladores alostericos positivos del receptor muscarinico m4 de la acetilcolina.

Country Status (11)

Country Link
US (3) US12331055B2 (https=)
EP (1) EP4182316A1 (https=)
JP (1) JP7766946B2 (https=)
KR (1) KR20230039701A (https=)
CN (1) CN116209446B (https=)
AU (1) AU2021308625A1 (https=)
BR (1) BR112023000760A2 (https=)
CA (1) CA3189217A1 (https=)
IL (1) IL299758B2 (https=)
MX (1) MX2023000580A (https=)
WO (1) WO2022015988A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4182316A1 (en) * 2020-07-15 2023-05-24 Vanderbilt University 7-(piperidin-1-yl)-4h-pyrimido[1,2-b]pyridazin-4-one derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4
WO2023114224A1 (en) 2021-12-13 2023-06-22 Sage Therapeutics, Inc. Combination of muscarinic receptor positive modulators and nmda positive allosteric modulators
WO2023141511A1 (en) * 2022-01-19 2023-07-27 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor m4
EP4611127A4 (en) 2022-12-02 2025-12-31 Lg Energy Solution Ltd BATTERY BLOCK AND ITS MANUFACTURING PROCESS
AU2024259614A1 (en) 2023-04-18 2025-10-02 Vanderbilt University Thiazolopyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4
KR20260035912A (ko) * 2023-06-22 2026-03-13 반더빌트유니버시티 무스카린성 아세틸콜린 수용체 m4의 양성 조절제
WO2025122733A1 (en) 2023-12-07 2025-06-12 Neumora Therapeutics, Inc. Crystalline forms of 7-((2r,4s)-4-((2,3-dihydrobenzo[b][1,4] dioxin-6-yl-2,2,3,3-d4)oxy)-2-methylpiperidin-1-yl)-8-methyl-4h-pyrimido[1,2-b]pyridazin -4-one
WO2026047494A1 (en) 2024-08-26 2026-03-05 Suven Life Sciences Limited 2-AMINO-PYRIMIDINE DERIVATIVES AS MUSCARINIC M4 RECEPTOR POSITIVE ALLOSTERIC MODULATORS (M4 PAMs)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9156833B2 (en) * 2012-07-16 2015-10-13 Barry University, Inc. Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof
WO2014122474A1 (en) 2013-02-07 2014-08-14 Takeda Pharmaceutical Company Limited Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists
US10329289B2 (en) * 2015-12-23 2019-06-25 Merck Sharp & Dohme Corp. 6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor
WO2017107087A1 (en) * 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. 6, 7-dihydro-5h-pyrrolo [3, 4-b] pyridin-5-oneallosteric modulators of the m4 muscarinic acetylcholine receptor
US10961253B2 (en) * 2016-11-07 2021-03-30 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
WO2018112843A1 (en) * 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018112842A1 (en) * 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6,6-fused heteroaryl piperidine ether allosteric modulators of m4 muscarinic acetylcholine receptor
WO2018112840A1 (en) * 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6, 5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2019000238A1 (en) * 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. 5- (PYRIDIN-3-YL) OXAZOLE ALLOSTERIC MODULATORS OF M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
EP4182316A1 (en) * 2020-07-15 2023-05-24 Vanderbilt University 7-(piperidin-1-yl)-4h-pyrimido[1,2-b]pyridazin-4-one derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4

Also Published As

Publication number Publication date
US11884676B2 (en) 2024-01-30
KR20230039701A (ko) 2023-03-21
US20230286991A1 (en) 2023-09-14
EP4182316A1 (en) 2023-05-24
JP2023534803A (ja) 2023-08-14
IL299758A (en) 2023-03-01
IL299758B2 (en) 2026-04-01
BR112023000760A2 (pt) 2023-02-07
US12331055B2 (en) 2025-06-17
US20250263417A1 (en) 2025-08-21
CN116209446A (zh) 2023-06-02
US20230257381A1 (en) 2023-08-17
IL299758B1 (en) 2025-12-01
WO2022015988A1 (en) 2022-01-20
JP7766946B2 (ja) 2025-11-11
AU2021308625A1 (en) 2023-02-09
CN116209446B (zh) 2025-05-13
CA3189217A1 (en) 2022-01-20

Similar Documents

Publication Publication Date Title
MX2023000580A (es) Derivados de 7-(piperidin-1-il)-4h-pirimido[1,2-b]piridazin-4-ona como moduladores alostericos positivos del receptor muscarinico m4 de la acetilcolina.
KR102857816B1 (ko) 포스포이노시티드 3-키나제 (pi3k) 조정과 연관된 질환의 치료를 위한 pi3k의 알로스테릭 크로메논 억제제
CN105294683B (zh) Cdk类小分子抑制剂的化合物及其用途
US9540392B2 (en) Thienopyrimidines
US9714232B2 (en) Substituted piperazine compounds and methods of use thereof
JP2021518441A (ja) Shp2ホスファターゼ阻害剤およびこれらの使用方法
MX385384B (es) Moduladores alostericos positivos del receptor muscarinico de acetilcolina m4
US10745420B2 (en) Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
US20230203041A1 (en) Antagonists of the adenosine a2a receptor
WO2009093209A3 (ru) 2-AЛKИЛAMИHO-3-APИЛCУЛЬФOHИЛ-ЦИKЛOAЛKAHO [e ИЛИ d] ПИPAЗOЛO [1,5-a] ПИPИMИДИHЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
US20170121323A1 (en) 2-amino-pyrido[2,3-d]pyrimidin-7(8h)-one derivatives as cdk inhibitors and uses thereof
WO2006067614A3 (en) Heteroaromatic derivatives useful as anticancer agents
US9974785B2 (en) Aromatic heterocyclic derivatives and pharmaceutical applications thereof
US20160159816A1 (en) Substituted thienopyrimidines and pharmaceutical use thereof
BR112018013882A2 (pt) moduladores alostéricos positivos do receptor muscarínico de acetilcolina m4
BR112018013763A2 (pt) moduladores alostéricos positivos do receptor muscarínico de acetilclona m4
WO2019113174A8 (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m4
MX2025015400A (es) Moduladores positivos del receptor de acetilcolina muscarinico m4
EP4444421A2 (en) Heterocyclic compounds as dyrk1a inhibitors
US20240182460A1 (en) Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease
US20250171463A1 (en) Emopamil-binding protein inhibitors and uses thereof
US20210017182A1 (en) Heterocyclic inhibitors of ptpn11
US20250388604A1 (en) Compounds and Their Use as PDE4 Activators
TWI690533B (zh) Cdk類小分子抑制劑的化合物及其用途
HK1210169B (en) Triazolopyrazine